Specialty Pharmacy

Aleksandar L. Krunic, MD, PhD, discusses treatment strategies for rare tumor types in Mohs disease during the 25th European Academy of Dermatology and Venereology Congress.

Illaris has been approved to treat 3 types of periodic fever syndromes.

Specialty pharmacy stakeholders continue to balances benefits versus risks with new specialty drug products.

The largest study to examine the relationship between anxiety and cancer death sheds light on the importance of taking anxiety seriously.

Top news of the day from across the health care landscape.

Eric Peacock, co-founder and CEO of MyHealthTeams, how bringing the voice of patients to clinical research can enhance health care.

Lower copays could improve cholesterol treatment adherence in minority communities.

Many patients wait until after becoming infected with HIV to seek treatment.

Ultrasound not deemed to be sufficiently sensitive to detect early stage liver cancer.

National Association of Specialty Pharmacy honors excellence in pharmacy, distinguished service at annual conference.

In-depth look at clinically appropriate drug use and cost-saving opportunities in Medicaid programs.

Only 12.8% of all experimental diabetes drugs transition to phase 3 trials.

New research highlights the need for earlier access to effective pain medications among advanced cancer patients.

Restoring defected mitochondrial function may be a new target for rare genetic disorder.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Daniel P. Kus, BS Pharm, RPh, discusses how the growth of drug prices could impact the specialty pharmacy patient experience.

Attacking dormant HIV cells shows promise eradicating disease.

Methods of trail that examined laquinimod for relapsing-remitting multiple sclerosis scrutinized by researchers.

Everything from seafood and steaks to French and Balkan cuisine, here is a list of highly rated restaurants in DC.

Top news of the day from across the health care landscape.

Specialty pharmacy providers are uniquely positioned to capture information on a wide array of outcomes.

Amgen’s biosimilar Amjevita approved for variety of anti-inflammatory diseases, however, ongoing litigation may prevent it from hitting the market.

Analysis compares endosonography with mediastinoscopy in non-small cell lung cancer.

Crohn’s disease patients often report concentration and thought problems.

Kevin James, RPh, MBA, vice president of payer strategy at US Bioservices, discusses how specialty pharmacies can navigate limited distribution networks.

Confidence intervals can improve adherence to disease modifying drugs in the care of multiple sclerosis.

Top news of the week in oncology, and cancer drug development.